Anne Brendel is an associate based in San Francisco and a member of Goodwin’s Life Sciences group and Healthcare practice.
Ms. Brendel focuses her practice on regulatory and transactional-support matters affecting a variety of health care industry clients, including telehealth companies, physician groups, pharmacies, ambulatory surgery centers, outpatient clinics, behavioral health providers, residential treatment centers, sober living facilities, and hospitals.
Ms. Brendel’s regulatory practice is concentrated on healthcare fraud and abuse, corporate practice, privacy, consent, Medicare and Medicaid enrollment, reimbursement and billing, licensing and certification, accreditation, and compliance. Ms. Brendel assists clients with meeting reporting and payment requirements under the Medicare 60-Day Rule and filing self-disclosures under the OIG’s Self-Disclosure Protocol for potential violations involving civil monetary penalties and CMS’s Voluntary Self-Referral Disclosure Protocol for potential Stark Law violations. She has experience responding to federal government subpoenas and civil investigative demands involving alleged fraudulent billing for professional services, lab diagnostic tests, and medications and negotiating settlements, including Corporate Integrity Agreements.
She also has healthcare service plan licensing experience and advises healthcare service plans with regard to compliance with California’s Knox-Keene Act.
